Chemours Sued for Securities Fraud After Opteon Demand Issues
The headline reports a securities fraud lawsuit against Chemours, following Opteon demand issues and an 18% stock drop.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
CC Class Action Notice: Chemours Sued for Securities Fraud After Opteon Demand Issues Lead to 18% Stock Drop — Investors Urged to Contact BFA Law by December 7 Deadline
For best results when printing this announcement, please click on link below: CC Class Action Notice: Chemours Sued for Securities Fraud After Opteon Demand Issues Lead to 18% Stock Drop — Investors Urged to Contact BFA Law by December 7 Deadline Chemours has been sued for securities fraud after its stock plummeted 18.